Doximity, Inc. $DOCS Stake Trimmed by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al decreased its holdings in shares of Doximity, Inc. (NYSE:DOCS) by 36.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 46,095 shares of the company’s stock after selling 26,938 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Doximity were worth $1,306,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of DOCS. Signaturefd LLC lifted its position in Doximity by 10.4% during the third quarter. Signaturefd LLC now owns 4,205 shares of the company’s stock valued at $119,000 after purchasing an additional 397 shares during the last quarter. Nisa Investment Advisors LLC increased its holdings in shares of Doximity by 59.9% in the 3rd quarter. Nisa Investment Advisors LLC now owns 1,855 shares of the company’s stock worth $53,000 after buying an additional 695 shares during the last quarter. Apella Capital LLC increased its holdings in shares of Doximity by 1.4% in the 3rd quarter. Apella Capital LLC now owns 59,488 shares of the company’s stock worth $1,647,000 after buying an additional 802 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Doximity by 19.8% in the 3rd quarter. GAMMA Investing LLC now owns 5,834 shares of the company’s stock worth $165,000 after buying an additional 963 shares during the last quarter. Finally, Leonteq Securities AG raised its position in shares of Doximity by 65.6% during the 1st quarter. Leonteq Securities AG now owns 2,912 shares of the company’s stock valued at $68,000 after buying an additional 1,154 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Needham & Company LLC reaffirmed a “buy” rating and issued a $41.00 price target on shares of Doximity in a report on Friday, August 7th. Weiss Ratings raised Doximity from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, October 6th. Wolfe Research raised Doximity to an “outperform” rating in a research note on Thursday, August 13th. Freedom Capital downgraded Doximity from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 8th. Finally, Stifel Nicolaus set a $27.00 price objective on Doximity in a research note on Tuesday, September 8th. Eight analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, Doximity currently has an average rating of “Hold” and an average target price of $30.73.

Key Headlines Impacting Doximity

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Valuation commentary points to potential upside: one article says a model sees about 53% upside, and another describes Doximity as roughly 3% undervalued following its DoseCheck and UpToDate rollout. These are model-based assessments, not guarantees or new company guidance. Earnings To Watch: Doximity Inc (DOCS) Q2 2027 — GF Value Sees 53% Upside Doximity Could Be 3% Undervalued Following DoseCheck And UpToDate Rollout
• Neutral Sentiment: Investors are looking ahead to Doximity’s fiscal Q2 2027 results for the quarter ended September 2026. The articles preview Wall Street estimates and key metrics but do not report results, so they provide no confirmed earnings surprise. Q2 Performance and Wall Street Estimates
• Negative Sentiment: Several law firms are publicizing a pending securities class action and a November 16, 2026 lead-plaintiff deadline. The complaint alleges Doximity overstated the Newsfeed product’s contribution to revenue growth and its competitive position; these are allegations, not established findings. Litigation can add uncertainty and reputational risk. DOCS Securities Class Action Deadline Alert

Insider Activity

In related news, Director Timothy Cabral sold 7,500 shares of the company’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $39.11, for a total transaction of $293,325.00. Following the transaction, the director directly owned 3,221 shares in the company, valued at approximately $125,973.31. This represents a 69.96% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Phoebe Yang sold 1,290 shares of the stock in a transaction dated Wednesday, September 30th. The stock was sold at an average price of $26.71, for a total transaction of $34,455.90. Following the completion of the sale, the director directly owned 24,744 shares in the company, valued at $660,912.24. This trade represents a 4.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 21,250 shares of company stock valued at $679,635 in the last quarter. 31.80% of the stock is currently owned by company insiders.

Doximity Stock Up 6.3%

NYSE DOCS opened at $34.64 on Thursday. The company has a fifty day moving average of $28.78 and a two-hundred day moving average of $25.59. The firm has a market capitalization of $6.17 billion, a price-to-earnings ratio of 35.82, a PEG ratio of 25.50 and a beta of 1.29. Doximity, Inc. has a 52 week low of $17.15 and a 52 week high of $66.11.

Doximity (NYSE:DOCS) last announced its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.13. The business had revenue of $156.62 million for the quarter. Doximity had a net margin of 25.48% and a return on equity of 18.06%. The company’s revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.36 EPS. Equities research analysts anticipate that Doximity, Inc. will post 0.74 EPS for the current year.

Doximity Profile

Doximity, Inc operates a digital platform designed for medical professionals in the United States. Its network connects physicians, nurse practitioners, physician assistants, pharmacists and other healthcare professionals, providing tools for professional communication, collaboration and career development.

The company offers services including secure messaging, telehealth, digital faxing, physician scheduling and professional networking. Doximity also provides medical news and educational content, as well as recruiting and job-search resources for healthcare professionals.

Doximity generates additional revenue through digital marketing and engagement solutions for pharmaceutical companies, healthcare organizations and health systems.